Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

GW Pharmaceuticals PLC

+ Add to Watchlist

GWPRF:US

7.2060 USD 0.1439 1.96%

As of 20:10:02 ET on 03/27/2015.

Company Profile for GW Pharmaceuticals PLC (GWPRF)

GW Pharmaceuticals plc researches and develops cannabinoid prescription medicines for the treatment of cancer pain, Multiple Sclerosis, and neuropathic pain.

Contact Information

GW Pharmaceuticals PLC

Porton Down Science Park
Salisbury
Wiltshire, SP4 0JQ
United Kingdom
Phone: 44-19-8055-7000
Fax: 44-19-8055-7111

Key Executives for GW Pharmaceuticals PLC (GWPRF)

Geoffrey William GuyChairman/FounderJustin David GoverChief Executive Officer
Adam David GeorgeCFO/SecretaryChristopher John Tovey "Chris"Chief Operating Officer
Stephen D SchultzVP:Investor RelationsStephen WrightDirector:Research & Dev

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil